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duced similar increased GAG and collagen release as when
co-incubated with cytokines. APC markedly increased MMP-2
activation (>80%) in IL-1 and TNF, but not RA treated cultures,
despite elevated pro-MMP-2 levels in the latter. APC increased
MMP-13 activity in IL-1 and TNF but not RA media, but could
not directly activate recombinant pro-MMP-13. APC did not sig-
nificantly modulate ADAMTS, MMP or TIMP expression when
administered alone or in combination with IL-1, TNF or RA.
Chondrocytes expressed mRNA for PC, EPCR and TM and
levels were not affected by APC or RA treatment. However,
IL-1 and TNF increased EPCR (1.7 & 3.8 fold, respectively)
and TM (5 and 18 fold, respectively) expression. PC was im-
munolocalised to chondrocytes in the presumptive joint space
prior to cavitation, the hypertrophic zone of the growth plate,
and throughout the depth of the cartilage in OA but not normal
joints.
Conclusions: Our results demonstrate that APC can act as an
efficient activator of MMPs in cartilage, inducing significant ag-
grecan and collagen degradation. Chondrocytes have previously
been shown to synthesise thrombin, and we have now demon-
strated that they express PC EPCR and TM necessary for its
efficient activation. PC was immunolocalised to chondrocytes in
areas of known MMP activity in growth cartilages and was in-
creased in OA. Catabolic cytokines known to be involved in OA
increased expression of TM and EPCR. Taken together, these
results suggest that APC may be a physiologically important
activator of MMPs in cartilage and regulating its activity could be
a novel target in the treatment of cartilage breakdown in arthritis.
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Purpose: The elevated levels of injury-induced pro-inflammatory
cytokines in the joint may play pivotal roles in the pathogenesis
of osteoarthritis. The objective of this study was to examine the
combined effects of TNF-α and IL-6/sIL6R on proteoglycan (PG)
degradation in mechanically-injured cartilage.
Methods: Immature bovine cartilage disks (3 mm diam, 1 mm
thick) from femoropatellar grooves were treated with either injuri-
ous compression (50% strain, 100%/second strain rate), rhTNF-α
(25 ng/ml), rhIL-6 (50 ng/ml) plus sIL-6R (250ng/ml), or combi-
nations of these three conditions. Culture was terminated after
6 days of treatment. In separate experiments, half the cartilage
disks were pre-equilibrated for 6 days with an IL-6 blocking Fab
fragment (50 ug/ml, Centocor, J&J) while the remaining disks
were incubated in normal medium. Afterward, disks were treated
with injurious compression, rhTNF-α (25 ng/ml), or injury + TNF-
α. Disks that were pre-treated with the Fab fragment continued to
receive it until the end of the experiment. sGAG release (DMMB)
and biosynthesis (35S-PG) were measured, and Western blot-
ting to identify G1-NITEGE aggrecan fragments was performed
on pooled medium. Selected cartilage samples were fixed in
gluteraldehyde (with RHT) and stained with Toluidine Blue.
Results: 3-way ANOVA followed by post-hoc Tukey’s pairwise
comparisons showed that TNF-α formed interactions with both
IL-6/sIL-6R and injurious compression causing increased sGAG
release and decreased PG synthesis. While IL-6/sIL-6R signif-
icantly augmented TNF-α-induced PG degradation, the largest
amount of GAG loss was caused by the combination of injury +
TNF-α + IL-6/sIL-6R. Histology showed that GAG loss was not
uniform in the disk cross-section but progressed from the disk
periphery towards the center with time. The most rapid, severe
GAG loss was observed in disks treated with the combination
of injury + TNF-α + IL-6/sIL-6R. Western blotting demonstrated
that the most dramatic release of aggrecanase-generated aggre-
can fragments occurred in response to treatment with TNF-α +
IL-6/sIL-6R, both with and without injurious compression. In sep-
arate studies, TNF-α + mechanical injury caused greater GAG
loss than either treatment alone. Importantly, the IL-6 blocking
Fab fragment significantly reduced the combined catabolic effects
of TNF-α + mechanical injury on GAG loss, with no exogenous
IL-6 present.
Conclusions: The combined treatment with TNF-α and IL-6/sIL-
6R induced significantly more GAG loss than either cytokine
alone, and this catabolic response was associated with aggre-
canase activity. Additionally, the catabolic effect of TNF-α, and
the combined effect of TNF-α + IL-6/sIL-6R are both highly po-
tentiated by mechanical injury. The degradative effects of injury
+ TNF-α appear to be due, in part, to the action of endogenous
IL-6, as sGAG loss was partly abrogated by the IL-6 blocking
Fab fragment. This result is also consistent with the increased
loss of sGAG upon addition of exogenous IL-6 to the combi-
nation of TNF-α and mechanical injury. Histology suggests that
the kinetics of cartilage degradation does not merely depend
on the activity of proteolytic enzymes, but also relies strongly
on the transport of cartilage biomolecules, which may be al-
tered by overload injury. In conclusion, this study suggests that
pro-inflammatory cytokines can interact to potentiate cartilage
catabolism. Chondrocyte-mediated catabolism, as well as trans-
port of cytokines and proteases in the matrix, may both be altered
by joint injury, making the damaged tissue more susceptible to
further degradation by biochemical mediators.
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Purpose: Calcitonin has recently been proposed as an effective
drug for the treatment of osteoarthritis (OA). We investigated
whether treatment with salmon calcitonin influences the local
content of proteoglycans in human OA articular cartilage and
whether treatment with oral salmon calcitonin effects articular
cartilage erosion in an in vivo experimental model of OA.
Methods: For investigations of chondrocyte-mediated effects of
salmon calcitonin we used human OA cartilage obtained from
knee arthroplasty operations, which was dissected into 12-14
mg explants and cultured for 16 days in four replicates with
refreshment of medium every second day in the presence or
absence of salmon calcitonin [1 nM-1 mM]. MMP-13 ELISA was
used to quantify MMP-13 activity in the conditioned medium, and
sulphated glycosaminoglycan (sGAG) was measured in N2 pul-
verized explants extracts by the alcian blue binding assay. The
ovariectomized (OVX) rat was used as a non-traumatic model
of accelerated cartilage loss accompanying estrogen deficiency.
Fifty rats were randomly allocated into five intervention groups
and treated for nine weeks: 1) Sham, 2) OVX, 3) OVX + s.c.
implanted 17-β-ethynyl-estradiol pellet, 4) OVX + daily oral dose
calcitonin [2 mg/kg] + vehicle, 5-CNAC [50 mg/kg], and 5) OVX
+ daily oral dose of vehicle 5-CNAC [50 mg/kg]. Extracts of
entire articular joints was used for biochemical analysis. The
articulatio cubiti joint were isolated, snap-frozen, pulverized in N2
and resuspended with protease inhibitors, and fragments of C-
